We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EUROFINS STRENGTHENS POSITION IN GLOBAL CLINICAL TRIALS MARKET WITH ACQUISITION OF FOCUS BIO-INOVA
EUROFINS STRENGTHENS POSITION IN GLOBAL CLINICAL TRIALS MARKET WITH ACQUISITION OF FOCUS BIO-INOVA
June 16, 2006
Eurofins Scientific strengthens its position in the global clinical trials market, and expands its testing services portfolio to the pharmaceutical and biotechnology industries with the acquisition of Focus Bio-Inova (FBI). Euronext
